This study examined the primary effect of selected cryoprotective agents (CPAs) on the meiotic spindles of human oocytes during cooling.
Fresh metaphase II oocytes (
Meiotic spindles remained visible or became more distinct during cooling to 20°C, 10°C and 0°C when equilibrated with PROH, EG, DMSO and Taxol. Without these agents, meiotic spindles of the same oocytes disappeared after cooling to 20°C.
The primary effect of PROH, EG and DMSO on the meiotic spindle is to stabilize and protect it against low temperature disassembly. A higher equilibration temperature (≥33°C) for oocyte freezing is recommended.
Studies on human oocyte cryopreservation over the last decade yielded only limited success, while human embryo cryopreservation has been performed successfully around the world for many years. The suboptimal results in oocyte cryopreservation may be a result of damage to meiotic spindle during freezing and thawing. The meiotic spindles in mammalian oocytes, including the human, are extremely sensitive to temperature change [
Due to concerns about toxicity of CPAs, oocytes are normally cooled to room temperature (18°C to 24°C) or even lower (4°C to 0°C) before equilibrating with CPAs [
The present research using a Polscope system and a cooling stage attached to the same microscope was designed to assess the impact of commonly used penetrating CPAs, (
Twelve patients (four of whom were oocyte donors) provided a total of 50 oocytes for this study. Eight of them who had 20 to 40 oocytes (mean 30.6 oocytes) available for IVF donated 3 to 5 oocytes each, two oocyte donors underwent split cycles without a second recipient donated half of the retrieved oocytes, and two patients who chose to inseminate limited number of oocytes for transfer donated half of their oocytes. Mean (±SD) age of patients was 30.58 ± 9.44 years. After screening oocytes for visible spindles using Polscope, all oocytes without visible spindle (
Controlled ovarian hyperstimulation was preceded by pituitary downregulation with GnRH agonist (Lupron; TAP, Deerfield, IL), followed by recombinant FSH (Follistim; Organon, Roseland, NJ) and hMG (Pergonal; Serono). 10,000IU hCG was used for triggering. Transvaginal oocyte aspiration was performed under i.v. sedation 35h after hCG injection. Following retrieval, oocytes were stripped of cumulus cells after being cultured in IVC-ONE medium (InVitroCare, Frederick, MD) supplemented with serum substitute (SSS; Irvine Scientific, Santa Ana, CA) for 2–4h.
Unless stated otherwise, all reagents were purchased from Sigma Chemical Company (St. Louis, MO, USA). All oocyte treatment solutions were prepared using Dulbecco’s phosphate-buffered solution (PBS) (Sage Biopharma, Bedminster, NJ) and contained a final concentration of 20% SSS (Irvine Scientific). Treatment solutions used were: (1)1.5M 1,2-propanediol (PROH); (2) 1.5M dimethyl sulfoxide (DMSO); (3) 1.5M ethylene glycol (EG) and (4) 10μM taxol.
For spindle imaging, each oocyte was placed in10μl of treatment solution covered with mineral oil (Medicult, Denmark) in a glass-bottomed culture dish (Willco Wells, Amsterdam, The Netherlands). An inverted microscope equipped with a Peltier system (PE100, Linkam Scientific Instruments Ltd, UK) was used for oocyte assessment and spindle examination. The Peltier system includes a biological warming and cooling microscope stage attached to a temperature controller with a range of −5°C to 99°C (PE-94, Linkam Scientific Instruments Ltd). Dishes were placed on the stage during equilibration and examination. During examination, oocytes were manipulated by holding pipette (Sunlight Medical, Jacksonville, FL) and/or partial zona dissection pipette (Sunlight Medical). The meiotic spindle visualization was performed at 200X magnification with LC Polscope optics and controller (SpindleView; CRI, Woburn, MA, USA) fitted to a computerized image analysis system (SpindleView software; CRI).
Details of the oocyte spindle status, experimental assignment and treatment subgroups are summarized in
Oocytes in Experiment 1 were cooled to 20°C at −5°C per minute, held for 5min and then rewarmed to 37°C at 5°C per minute, to measure spindle response to temperature change. Oocytes showing a positive response to temperature change (
Oocytes were then exposed to one of four treatment solutions at 37°C x 10min. The stage temperature was then dropped to and held for 10min at 20°C, 10°C, 0°C and then rewarmed to 37°C. Spindle images were taken 5 and 10min after reaching the desired temperatures. The experiment was repeated on at least three oocytes for each agent.
Oocytes without visible spindle at 37°C in PBS were cooled to 20°C and then exposed to PROH, EG and taxol at 20°C x 10min. Polscope images were taken before treatments, at 5 and 10 min after equilibration in each treatment solution at 20°C. Cryoprotectants were removed by washing oocytes in PBS three times. The oocytes were then maintained in PBS at 20°C for 10 min before rewarming to 37°C. Next, oocytes were cultured 18–20h in our embryo culture medium (IVC-ONE supplemented with 5% SSS) at 37°C. Polscope images were recorded 5 and 10min after removal of cryoprotectants at 20°C, after 30 minutes in culture at 37°C, and after overnight culture before discarding. The experiment was repeated on at least three oocytes for each agent. DMSO was omitted from this experiment since it induced an extra spindle structure in 2 of 4 treated oocytes. It was our concern that DMSO may not be a suitable human oocyte freezing reagent given this finding.
Oocyte assignment to each treatment group, responses to temperature modifications and various cryoprotectants are illustrated in
The spindle dynamics in response to temperature change without any CPA served as a control for each oocyte group. The oocytes were then equilibrated with one of the four treatment solutions (PROH, EG, DMSO and taxol) at 37°C. Within 5min after oocyte equilibration in each reagent, the spindle images became larger (A4, C4) and/or more intense (B4, D4) than in PBS. Two of the four oocytes treated with DMSO developed an extra spindle structure (C4). Oocyte spindles in all four treatment solutions were clearly visible after the temperature was dropped to 20°C (row 5), 10°C (row 6) and even 0°C (row 7). Multiple irregular spindles were observed in the taxol group at temperatures down to 0°C (D6, D7), and this formation continued following oocyte rewarming to 37°C (D8). Spindle images of oocytes in EG became weaker at 10°C (B6) and 0°C (B7) compared to 20°C (B5) and 37°C (B8), while in PROH and DMSO spindles showed no obvious changes at 20°C (A5, C5), 10°C (A6, C6), 0°C (A7, C7) or after warming to 37°C (A8, C8) (including extra spindle structure in the DMSO treated oocyte).
Spindle dynamics of human oocytes equilibrated with PROH, EG and taxol at 20°C (and their response to cooling and removal of the protective compounds) were studied in Experiment 2. None of the oocytes showed a spindle structure after being cooled to 20°C before equilibration with one of the three treatment solutions. Spindles became clearly visible 5min after being placed in each treatment solution (row 2). The spindles disappeared within 5min following removal of PROH (P3) and EG (E3), but not in the oocyte treated with taxol (T3). Spindle formation continued even after taxol was washed out and cultured in PBS at 37°C for 30 minutes (T3). Spindles in oocytes treated with EG (E4) and taxol (T4) appeared normal after overnight culture. No spindle could be identified in two of the four oocytes treated with PROH after overnight culture (P4). Weak spindle images were seen in the other two oocytes treated with PROH.
Cryoprotective agents have been reported to have beneficial effects on the meiotic spindle of mouse and human oocytes [
Rienzi
Rienzi
The disappearance of spindle after thaw is of clinical concern. Embryos and oocytes are normally thawed at room temperature and cultured through a sequence of media to remove CPAs before they are cultured in an incubator at 37°C or transferred. The meiotic spindle is a dynamic structure of cytoskeletal filaments, undergoing rapid structural reorganization including filament disassembly at one site and reassembly at another [
It is common practice to cool oocytes to room temperature (18–24°C) [
Reports on CPA effects on the microfilament system are varied, and may be influenced by reagent concentration [
Besides stabilizing the microfilament system, DMSO was associated with the formation of an extra spindle, suggesting a direct or indirect ability to promote polymerization. DMSO has been reported to form multiple cytoplasmic microtubular asters in mouse oocytes [
The protective effect of CPAs is poorly understood. It has been postulated that CPAs may act by reducing the concentration of intracellular electrolytes, by stabilizing plasma membrane by electrostatic interactions, and by reducing the rates of ice nucleation and crystal growth by increasing the viscosity of extra- and intracellular solutions [
Taxol, an antitumor drug [
This study examined spindle responses to cooling up to 0°C in presence of selected CPAs. It may not represent spindle response to freezing at −196°C when a few CPAs are often used in clinical oocyte cryopreservation. The reason for the weak or no spindle formation among oocytes treated with PROH (compared to EG and taxol treated oocytes) after overnight culture (Experiment 2) is unknown. More research is needed to identify the cause(s) of such spindle loss.
The present study demonstrates the ability of CPAs to stabilize and protect the meiotic spindle of human oocytes against cooling. It is recommended that oocytes should always be equilibrated with freezing solutions at physiological temperature (37°C), or at least 33°C [
This study was supported in part by Organon USA Inc., Roseland, New Jersey, USA. The sponsor had no involvement in study design, data collection, analysis or interpretation of data, in the writing of the report, or in the decision to submit the paper for publication.
Oocyte allocation for Experiments 1 and 2 with summary of response to selected cryoprotectants.
Spindle images of human oocytes following cooling and treatment with cryoprotective agents (Experiment 1). Images in column A, B, C, and D (representing four treatment groups, PROH, EG, DMSO and taxol respectively) were taken after oocytes were maintained in PBS at 37°C (row 1), after temperature dropped to 20°C (row 2), then rewarmed to 37°C (row 3), after having been equilibrated with the cryoprotective agents at 37°C (row 4), after temperature dropped to 20°C (row 5), 10°C (row 6), 0°C (row 7) and then rewarmed to 37°C (row 8). Arrow outlines show spindles while solid arrows in column C indicate newly formed extra spindle structures [original magnification = 200X].
Spindle images of human oocytes equilibrated with cryoprotective agents at 20°C (Experiment 2). Polscope images of oocytes in PROH, EG and taxol groups (Column P = PROH, E = EG and T= taxol) were recorded at 37°C in PBS (row 1), after equilibration with cryoprotective agents at 20°C (row 2), after cryoprotective agents were removed (row 3), and after being cultured overnight at 37°C (row 4). Spindles are designated by white arrows [original magnification = 200X].